awards grant
- A Non-Inferiority Randomized Controlled Clinical Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Consequent to MST in Male and Female Military Personnel and Veterans
- A Phase II Study of Inhaled CO for the Treatment of ARDS
- A sUPR driver of T cell metabolic dysfunction in ovarian cancer
- A smart soft robotic tool for semi-automated intubation
- ATF4 in ccRCC: A New Therapeutic Approach
- Bcl-xL in breast cancer metastasis and therapy
- Characterizing 3''-UTR biology as a mechanism of therapy response in high risk prostate cancer.
- Clinical identification and targeting of non-neuroendocrine lineage plasticity in castration-resistant prostate cancer
- Clonal Hematopoiesis as a determinant for bone marrow toxicities for targeted radiation therapies in prostate cancer.
- Converting HR Breast Cancer Into an Individualized Vaccine
- Converting HR+ Breast Cancer Into an Individualized Vaccine
- Decoding Bone Metastasis in Prostate Cancer: A Multimodal Approach Integrating Genomics and Imaging Data
- Defining the impact of Kras mutational heterogeneity on the tumor microenvironment in pancreatic cancer
- Defining the impact of Kras mutational heterogeneity on the tumor microenvironment in pancreatic cancer
- Determining Metastatic Drivers of Pten/p53-Loss-Driven Prostate Cancer Using Evolving DNA Barcodes
- Dissecting the role of folate deficiency in lung cancer development and genomic instability
- Early detection blood test for universal breast cancer screening to improve early diagnosis for women of all social and ethnic backgrounds
- Elucidating the oncogenic role of EMSY in non-small cell lung cancer
- Enhancing Breast Cancer Therapy by Inhibiting the Adenosine Receptor and Oxygen Consumption
- Extending the survival of HR+ breast cancer patients receiving CDK4/6 inhibitors by targeting IL17-producing gamma delta T cells
- Heating cold prostate tumors with PSMA-targeted alpha therapy and pembrolizumab
- Mechanism-Based Approach for Combination Therapies with Immune Modulation for Management of Patients with Urothelial Cancers of the Upper Urinary Tract
- Molecular and clinical correlates with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy
- Mutational and Aging Risk Factors for Myelodysplastic Syndrome
- Novel Approach to Improving Prostate Cancer Screening Among African American Men
- Novel Complex Structural Variants And Epigenetic Alterations Link The Genomes Of Prostate Cancer In African Americans With Outcome Disparity.
- Nutrition-Based Programming of Dendritic Cells for Ovarian Cancer Immunotherapy
- Restoration of Clear Cell Renal Cell Carcinoma Tumorigenicity by Cell Reprogramming
- Role of functional factors in AR reprogramming and progression of prostate cancer
- Targeted Therapies
- Targeting APOBEC3A-induced chromosomal instability as a driver of metastasis in bladder cancer
- Targeting Inflammatory Pathways in Breast Cancer Brain Metastases for the Treatment of Edema and Radiation Necrosis Using Anti-VEGF Ultrasmall Particle Therapy
- Targeting ecDNA to reverse therapy-resistance in urothelial cancer.
- The Impact of Staffing Levels on Access, Quality and Utilization: Evidence from Primary Care
- The Skeletal Stem Cell Basis for Skeletal Fragility
- Theranostic Trop-2-directed pretargeted radioimmunotherapy for metastatic prostate cancer with curative intent
- Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory
- Therapeutic targeting of the tumor microenvironment in triple negative breast cancer patients at high risk of relapse and preclinical models of lung metastases
- Ultrasmall PSMA-Targeted Particle Radiotherapy for Regulating the Immunosuppressive Prostate Cancer Tumor Microenvironment and Enhancing Treatment Efficacy